(RTTNews) - Catalent, Inc. (CTLT), a provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, Monday said it has agreed to sell its oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results